Evidence map›Paper›PMID 31443533›Full record

ArticleMolecules (Basel, Switzerland)2019

Cubic Liquid Crystalline Nanostructures Involving Catalase and Curcumin: BioSAXS Study and Catalase Peroxidatic Function after Cubosomal Nanoparticle Treatment of Differentiated SH-SY5Y Cells.

Miora Rakotoarisoa, Borislav Angelov, Shirly Espinoza, Krishna Khakurel, Thomas Bizien, Angelina Angelova

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Assessment of the Potential ofFrontiers in pharmacology · 2022
    Article
  13. A GdWMolecules (Basel, Switzerland) · 2021
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Miora RakotoarisoaInstitut Galien Paris-Sud, CNRS UMR 8612, Univ. Paris-Sud, Université Paris-Saclay, LabEx LERMIT, F-92290 Châtenay-Malabry CEDEX, France.
Borislav AngelovInstitute of Physics, ELI Beamlines, Academy of Sciences of the Czech Republic, Na Slovance 2, CZ-18221 Prague, Czech Republic.
Shirly EspinozaInstitute of Physics, ELI Beamlines, Academy of Sciences of the Czech Republic, Na Slovance 2, CZ-18221 Prague, Czech Republic.
Krishna KhakurelInstitute of Physics, ELI Beamlines, Academy of Sciences of the Czech Republic, Na Slovance 2, CZ-18221 Prague, Czech Republic.
Thomas BizienSynchrotron SOLEIL, l'Orme des Merisiers, Saint-Aubin - BP 48, 91192 Gif-sur-Yvette CEDEX, France.
Angelina AngelovaInstitut Galien Paris-Sud, CNRS UMR 8612, Univ. Paris-Sud, Université Paris-Saclay, LabEx LERMIT, F-92290 Châtenay-Malabry CEDEX, France. angelina.angelova@u-psud.fr.ORCID 0000-0002-0285-0637
FZU ‒ Institute of Physics of the Academy of Sciences of the Czech Republic · CZUniversité Paris-Sud · FRSynchrotron soleil · FR

Funding

Agence Nationale de la Recherche IDEX Paris-Saclay, "IDI 2017" project ANR-11-IDEX-0003-02Czech Academy of Sciences/Akademie Věd České Republiky MSM100101901European Regional Development Fund ELIBIO CZ.02.1.01/0.0/0.0/15_003/0000447Grantová Agentura České Republiky 17-00973SMinisterstvo Školství, Mládeže a Tělovýchovy (CZ) LQ1606
6 · The paper itself

Abstract

The development of nanomedicines for the treatment of neurodegenerative disorders demands innovative nanoarchitectures for combined loading of multiple neuroprotective compounds. We report dual-drug loaded monoolein-based liquid crystalline architectures designed for the encapsulation of a therapeutic protein and a small molecule antioxidant. Catalase (CAT) is chosen as a metalloprotein, which provides enzymatic defense against oxidative stress caused by reactive oxygen species (ROS) such as hydrogen peroxide (H

Indexed as

CatalaseCurcuminHumansHydrogen PeroxideImaging, Three-DimensionalLiquid CrystalsNanostructuresPolyethylene GlycolsReactive Oxygen SpeciesScattering, Small AngleSynchrotronsCatalaseCurcuminHydrogen Peroxidepolyethylene glycol 1000Polyethylene GlycolsReactive Oxygen SpeciesBioSAXScatalasecubosomecurcuminfish oilliquid crystalline nanoparticlesperoxidatic activity of catalase

Identifiers

PMID31443533
PMCPMC6749324
OpenAlexW2969479447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.